New study could boost vaccination argument for Merck's Gardasil

18th May 2017 Uncategorised 0

As U.S. doctors and health officials hustle to drive up HPV vaccination rates, a new study suggests Merck’s Gardasil may protect against head and neck cancers, an indication that’s not on the vaccine’s official list.

More: New study could boost vaccination argument for Merck's Gardasil
Source: fierce